Itero Biopharmaceuticals Raises $21M
San Mateo-based Itero Biopharmaceuticals, a developer of novel therapeutic proteins and antibodies, said Wednesday that it has raised $21M in a Series A venture funding. The funding came in conjunction with a partnership with Indian firm Biological E. Limited. According to Itero, the firm and Biological E. will collaborate on obtaining worldwide approvals and commercialize jointly developed biopharmaceuticals.
posted on Wednesday, June 11, 2008 (Link to more information)
Related companies:
ITERO Biopharmaceuticals
Related stories:
> NGM Biopharmaceuticals Get $51M
> CiVi Biopharma Takes $40M
> Principia Biopharma Raises $50M
> Labrys Biologics Raises $31M
> Jennerex Raises $5M
silicontap.com Home